1. DUPUYTREN'S CONTRACTURES

2. OSLER'S NODES

3. ABNORMAL BP MEASUREMENTS

4. ACS-PRE-HOSPITAL MANAGEMENT

5. ACUTE CORONARY SYNDROME

6. ACUTE CORONARY SYNDROME-ANTERIOR VS INFERIOR MI

7. ACUTE CORONARY SYNDROME-GENERAL MEASURES

8. ACUTE CORONARY SYNDROME-INVESTIGATION

9. ACUTE CORONARY SYNDROME-SUMMARY OF MANAGEMENT

10. ADDED HEART SOUNDS

11. ANKLE OEDEMA

12. ANTI-ANGINAL DRUGS

13. ANTI-ANGINAL DRUGS-ANTICOAGULATION

14. ARRHYTHMIAS CAUSING SYNCOPE

15. ARRHYTHMIAS-MONOMORPHIC VT MANAGEMENT

16. ARRHYTHMIAS-MONOMORPHIC VT

17. ARRHYTHMIAS-POLYMORPHIC VT MANAGEMENT

18. ARRHYTHMIAS-POLYMORPHIC VT

19. ARRHYTHMIAS-VENTRICULAR TACHYCARDIA (VT)

20. ARRHYTHMIAS-VT DRUGS

21. BP MEASUREMENT

22. CARDIAC ABDOMINAL FINDINGS

23. CARDIAC AREAS

24. CARDIAC DYSPNOEA

25. CARDIAC ISCHEMIA-ANGINA

26. CARDIAC ISCHEMIA-PROGNOSIS & OUTCOMES

27. CARDIAC MURMURS

28. CARDIAC STRESS TESTS-CONTRAINDICATIONS

29. CARDIAC STRESS TESTS-ECHO

30. CARDIAC STRESS TESTS-GUIDE

31. CARDIAC STRESS TESTS-IMAGE TESTING

32. CARDIAC STRESS TESTS-INIDCATIONS

33. CARDIAC STRESS TESTS-MPI

34. CARDIOVASCULAR RISK FACTORS

35. CAUSES OF ABNORMAL APEX BEAT

36. CAUSES OF ACUTE CHEST PAIN

37. CAUSES OF CARDIAC ARREST

38. CAUSES OF JVP ABNORMALITIES

39. CAUSES OF PITTING B/L LL OEDEMA

40. CAUSES OF POSTURAL HYPOTENSION

41. CAUSES OF PULSUS PARADOXUS

42. CAUSES OF SECONDARY HYPERTENSION

43. CAUSES OF SPLINTER HAEMORRHAGES

44. CAUSES OF SYNCOPE

45. CAUSES OF UNILATERAL PITTING OEDEMA

46. CHRONIC STABLE ANGINA-BETA BLOCKERS & ACEI

47. CHRONIC STABLE ANGINA-INVESTIGATION

48. CHRONIC STABLE ANGINA-MANAGEMENT

49. CORONARY ANGIOGRAPHY

50. CORONARY VESSELS

51. DIVISION OF OEDEMA

52. DRUGS CAUSING SYNCOPE

53. DYNAMIC CARDIAC AUSCULTATION MANOEUVRES

54. FINGER CLUBBING

55. HEART SOUNDS ABNORMALITIES

56. HYPERLIPIDEMIA RISK

57. HYPERTENSION EXAMINATION

58. JANEWAY LESIONS

59. JVP CHARACTERISTICS

60. LOWER LIMB VASCULAR EXAMINATION

61. MISCELLANEOUS ADDED HEART SOUNDS

62. NON-PITTING LL OEDEMA

63. ORTHOPNOEA

64. PALPITATIONS

65. PAROXYSMAL NOCTURNAL DYSPNOEA

66. PERIPHERAL VASCULAR DISEASE RISK FACTORS

67. PERIPHERAL VASCULAR DISEASE SIGNS

68. PULMONARY ARTERY CATHETERIZATION

69. PULMONARY ARTERY CATHETERIZATION-NORMAL PRESSURES

70. PULSE CHARACTERISTICS

71. RAISED JVP FINDINGS

72. SECONDARY HYPERTENSION-CLINICAL

73. SECONDARY HYPERTENSION-INVESTIGATIONS

74. VENOUS ULCER CHARACTERISTICS

75. XANTHOMATA

1. ACROMEGALY COMPLICATIONS

2. ACROMEGALY INVESTIGATION

3. ACROMEGALY MANAGEMENT

4. ACROMEGALY

5. ACTH

6. ADRENAL GLAND-CORTEX

7. ADRENAL GLAND-MEDULLA

8. ANDROGENS

9. ANTERIOR PITUITARY

10. APATHETIC HYPERTHYROIDISM

11. CALCIUM-CALCITONIN

12. CALCIUM-HYPERCALCEMIA CAUSES

13. CALCIUM-HYPERCALCEMIA MANAGEMENT

14. CALCIUM-HYPOCALCEMIA CAUSES

15. CALCIUM-METABOLISM

16. CAUSES OF DIABETES INSIPIDUS

17. CAUSES OF HYPERPROLACTINEMIA

18. CAUSES OF HYPERTHYROIDISM

19. CHRONIC AUTOIMMUNE THYROIDITIS

20. CHYLOMICRONS

21. CLINICAL FEATURES OF ACROMEGALY

22. CUSHING SYNDROME-CAUSES

23. CUSHING SYNDROME-CLINICAL

24. CUSHING SYNDROME-INVESTIGATIONS

25. DIABETES INSIPIDUS INVESTIGATION

26. DIABETES INSIPIDUS MANAGEMENT

27. DIABETES MELLITUS

28. DIABETES MELLITUS-ALPHA-GLUCOSIDASE INHIBITORS

29. DIABETES MELLITUS-BIGUANIDES

30. DIABETES MELLITUS-COMPLICATION MONITORING

31. DIABETES MELLITUS-COMPLICATIONS

32. DIABETES MELLITUS-GESTATIONAL DIABETES

33. DIABETES MELLITUS-GLITAZONES

34. DIABETES MELLITUS-GLYCEMIC TREATMENT GOALS

35. DIABETES MELLITUS-HHNK

36. DIABETES MELLITUS-HTN MANAGEMENT

37. DIABETES MELLITUS-INVESTIGATION

38. DIABETES MELLITUS-KETOACIDOSIS INX & MGM

39. DIABETES MELLITUS-KETOACIDOSIS

40. DIABETES MELLITUS-NEWER AGENTS

41. DIABETES MELLITUS-PRE-DIABETES INX

42. DIABETES MELLITUS-SECRETAGOGUES

43. DIABETES MELLITUS-TYPE 1

44. DIABETES MELLITUS-TYPE 1, MANAGEMENT

45. DIABETES MELLITUS-TYPE 2

46. DIABETES MELLITUS-TYPE 2, MANAGEMENT

47. DIABETIC AMYOTROPHY

48. DOWN-REGULATION OF LDL RECEPTORS

49. FAMILIAL HYPOCALCEURIC HYPERCALCEMIA

50. GH

51. GLUCOCORTICOIDS

52. GRAVES DISEASE CLINICAL FEATURES

53. GRAVES INVESTIGATION

54. GRAVES MEDICAL MANAGEMENT

55. GRAVES SURGICAL MANAGEMENT

56. HYPERTHYROIDISM CLINICAL FEATURES

57. HYPERTHYROIDISM DIFFERENTIALS

58. HYPERTHYROIDISM INVESTIGATION

59. HYPOGLYCAEMIA-CLINICAL

60. HYPOGLYCAEMIA-DIAGNOSIS

61. HYPOGLYCAEMIA-INVESTIGATION

62. HYPOGLYCEMIA

63. HYPOGLYCEMIA-NON-REACTIVE HYPOGLYCEMIA

64. HYPOTHYROIDISM CLINICAL FINDINGS

65. HYPOTHYROIDISM COMPLICATIONS

66. HYPOTHYROIDISM INVESTIGATION

67. HYPOTHYROIDISM MANAGEMENT

68. IGF-1

69. LH + FSH

70. LIPOPROTEIN PATHWAYS

71. MINERALOCORTICOIDS

72. MULTINODULAR GOITER INVESTIGATION

73. MULTIPLE ENDOCRINE NEOPLASIA

74. MYXEDEMA COMA CLINICAL FEATURES

75. MYXEDEMA COMA INVESTIGATION

76. MYXEDEMA COMA MANAGEMENT

77. NEGATIVE AND POSITIVE FEEDBACK

78. NON-TOXIC GOITER

79. OSTEOMALACIA

80. OSTEOPOROSIS-DIAGNOSIS

81. OSTEOPOROSIS-PREVENTION

82. OSTEOPOROSIS-RISK FACTORS

83. OSTEOPOROSIS-SCREENING

84. OSTEOPOROSIS-SUPPLEMENTATION

85. PAINLESS THYROIDITIS

86. PHAEOCHROMOCYTOMA

87. PHAEOCHROMOCYTOMA-COMPLICATIONS

88. PHAEOCHROMOCYTOMA-IMAGING

89. PHAEOCHROMOCYTOMA-INVESTIGATION

90. PHAEOCHROMOCYTOMA-MANAGEMENT

91. PHAEOCHROMOCYTOMA-RISK FACTORS

92. PITUITARY APOPLEXY

93. PITUITARY INCIDENTALOMA

94. PITUITARY INVESTIGATIONS

95. PITUITARY METASTASIS

96. PITUITARY TUMORS

97. POSTERIOR PITUITARY

98. POSTPARTUM THYROIDITIS

99. PRE-DIABETES

100. PRIMARY HYPERPARATHYROIDISM-INTRODUCTION

101. PRIMARY HYPERPARATHYROIDISM-INVESTIGATION

102. PRIMARY HYPERPARATHYROIDISM-MANAGEMENT

103. PRL

104. PROLACTINOMA

105. PTH

106. SECONDARY/TERTIARY HYPERPARATHYROIDISM

107. SHEEHAN SYNDROME

108. SICK EUTHYROID SYNDROME

109. SOLITARY NODULE INVESTIGATION

110. SUBACUTE THYROIDITIS

111. THYROID CA

112. THYROID FUNCTION TEST

113. THYROID HORMONE SYNTHESIS

114. THYROID NODULE OVERVIEW

115. THYROID NODULE RISK FACTORS

116. THYROID STORM MANAGEMENT

117. THYROID STORM

118. THYROID UPTAKE SCAN

119. THYROTROPHS

120. TOXIC ADENOMA

121. TOXIC MNG

122. TSH

123. UP-REGULATION OF LDL RECEPTORS

124. VITAMIN D SYNTHESIS

1. ACHALASIA-CLINICAL

2. ACHALASIA-DIAGNOSIS

3. ACHALASIA-MANAGEMENT

4. ACHALASIA-PATHOLOGY

5. ACUTE PANCREATITIS-ACUTE TREATMENT

6. ACUTE PANCREATITIS-CAUSES

7. ACUTE PANCREATITIS-COMPLICATION MANAGEMENT

8. ACUTE PANCREATITIS-DAILY EVALUATION

9. ACUTE PANCREATITIS-FLUID COLLECTIONS

10. ACUTE PANCREATITIS-INVESTIGATIONS

11. ACUTE PANCREATITIS-PSEUDOCYST

12. ACUTE PANCREATITIS-SCORING SYSTEMS

13. ACUTE PANCREATITIS-SEVERITY

14. ACUTE PANCREATITIS-SIGNS

15. AUTOIMMUNE PANCREATITIS

16. CAUSES OF RAISED AMYLASE & ABDOMINAL PAIN

17. CBD STONES

18. CHOLANGITIS

19. CHOLELITHIASIS-INVESTIGATIONS

20. CHOLELITHIASIS-MANAGEMENT

21. CHOLELITHIASIS-PATHOLOGY

22. CHOLELITHIASIS-RISK FACTORS

23. CHRONIC PANCREATITIS-CAUSES

24. CHRONIC PANCREATITIS-COMPLICATIONS

25. CHRONIC PANCREATITIS-DIAGNOSIS

26. CHRONIC PANCREATITIS-INVESTIGATIONS

27. CHRONIC PANCREATITIS-TREATMENT

28. COLON CANCER-COLONOSCOPY

29. COLON CANCER-DIAGNOSIS

30. COLON CANCER-MANAGEMENT

31. COLON CANCER-PATHOLOGY

32. COLON CANCER-RISK FACTORS

33. COLON CANCER-SCREENING

34. COLON CANCER-STAGING

35. COLON

36. DYSPHAGIA-CAUSES

37. GLUCAGONOMA

38. MALABSORPTION-BOWEL RESECTION

39. MALABSORPTION-STEATORRHEA

40. OESOPHAGEAL SCLERODERMA AND SYSTEMIC SCLEROSIS

41. OESOPHAGEAL SCLERODERMA AND SYSTEMIC SCLEROSIS-MANAGEMENT

42. OESOPHAGEAL SCLERODERMA AND SYSTEMIC SCLEROSIS-PATHOLOGY

43. PANCREATIC CANCER-CAUSES

44. PANCREATIC CANCER-INVESTIGATIONS

45. PANCREATIC CANCER-PRESENTATION

46. PANCREATIC CANCER-TREATMENT

47. PRIMARY SCLEROSING CHOLANGITIS

48. PRIMARY SCLEROSING CHOLANGITIS-DIFFERENTIALS

49. PRIMARY SCLEROSING CHOLANGITIS-INVESTIGATIONS

50. PRIMARY SCLEROSING CHOLANGITIS-MANAGEMENT

51. PRIMARY SCLEROSING CHOLANGITIS-PATHOLOGY

52. SWALLOWING DYSFUNCTION

53. SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)

1. ANEMIA-CAUSES

2. DISORDERS OF SECONDARY HEMOSTASIS

3. HEMOSTASIS-INTRODUCTION

4. HEMOSTASIS-PRIMARY HEMOSTASIS (PLT AGGREGATION)

5. HEMOSTASIS-SECONDARY HEMOSTASIS (COAGULATION CASCADE)

6. HEPARIN INDUCED THROMBOCYTOPENIA (HIT)

7. NOAC-AF & VALVULAR HEART DISEASE

8. NOAC-AF

9. NOAC-CHOOSING BETWEE NOAC & WARFARIN

10. NOAC-CHOOSING BETWEEN NOACs

11. NOAC-DVT & PE

12. NOAC-MANAGEMENT OF BLEEDING

13. NOAC-PHARMACOLOGY

14. NOAC-VTE PROPHYLAXIS

15. WARFARIN

1. CHLAMYDIA TRACHOMATIS

2. INFECTIVE ENDOCARDITIS-STIGMATA

3. MALARIA

4. MALARIA-MANAGEMENT

5. MALARIA-P. FALCIPARUM

6. MALARIA-P. VIVAX

7. PNEUMOCCAL MENINGITIS

8. SPLENECTOMY & S. PNEUMONIAE

1. ACE INHIBITORS & ARB

2. ACEI & ARB COMPLICATIONS

3. ACID-BASE DISORDERS

4. ACIDOSIS & CALCIUM

5. ACUTE INTERSTITIAL NEPHRITIS

6. ACUTE INTERSTITIAL NEPHRITIS-CLINICAL

7. ACUTE INTERSTITIAL NEPHRITIS-MANAGEMENT

8. ACUTE KIDNEY INJURY (AKI)

9. ACUTE KIDNEY INJURY (AKI)-CANCER

10. ACUTE KIDNEY INJURY (AKI)-NSAIDs

11. ACUTE TUBULAR NECROSIS

12. ALDOSTERONE, ALKALEMIA & POTASSIUM

13. ALKALEMIA & CALCIUM

14. ALPORT’S SYNDROME

15. ANALGESIC ABUSE NEPHROPATHY

16. ANION GAP

17. ANTI-DIURETIC HORMONE

18. ATN PATHOLOGY

19. ATN-INVESTIGATIONS

20. ATN-MANAGEMENT

21. BETA-BLOCKERS

22. CALCIUM CHANNEL BLOCKERS

23. CALCIUM

24. CENTRAL PONTINE MYELINOLYSIS

25. CHRONIC INTERSTITIAL NEPHRITIS-CAUSES

26. CHRONIC KIDNEY DISEASE (CKD)

27. CKD-ADYNAMIC BONE DISEASE

28. CKD-ANAEMIA

29. CKD-ANEMIA

30. CKD-CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)

31. CKD-DIALYSIS CLEARANCE

32. CKD-DOSE REDUCTION

33. CKD-GADOLINIUM

34. CKD-HEMODIALYSIS

35. CKD-MANAGEMENT

36. CKD-MINERAL AND BONE DISORDER

37. CKD-RENAL OSTEODYSTROPHY

38. CKD-RENAL TRANSPLANT

39. CKD-UREMIA

40. CONTRAST-RELATED AKI

41. DIABETIC NEPHROPATHY

42. DIURETIC-ALDOSTERONE INHIBITORS/K-SPARING

43. DIURETIC-CARBONIC ANHYDRASE INHIBITORS

44. DIURETIC-GUIDE

45. DIURETIC-LOOP DIURETICS

46. DIURETIC-THIAZIDE DIURETICS

47. DRUGS & ATN

48. EARLY DISTAL TUBULE

49. FRACTIONAL EXCRETION OF SODIUM

50. GFR

51. GLOMERULAR DISEASE

52. GLOMERULAR DISEASE-CASTS

53. GLOMERULAR DISEASE-INVESTIGATIONS

54. GLOMERULAR DISEASE-MISCELLANEOUS

55. GLOMERULAR DISEASE-NEPHRITIC SYNDROME INX

56. GLOMERULAR DISEASE-NEPHRITIC SYNDROME

57. GLOMERULAR DISEASE-NEPHRITIC VS NEPHROTIC

58. GLOMERULAR DISEASE-NEPHROTIC SYNDROME COMPLICATIONS

59. GLOMERULAR DISEASE-NEPHROTIC SYNDROME INX

60. GLOMERULAR DISEASE-NEPHROTIC SYNDROME MANAGEMENT

61. GLOMERULAR DISEASE-NEPHROTIC SYNDROME

62. GLOMERULUS-HISTOLOGY

63. GOODPASTURE SYNDROME

64. HAEMATURIA-CAUSES

65. HENDERSON-HASSELBACH EQUATION

66. HYPERNATREMIA

67. HYPERNATREMIA-HYPERVOLEMIC HYPERNATREMIA

68. HYPERNATREMIA-HYPOVOLEMIC HYPERNATREMIA

69. HYPERNATREMIA-NORMOVOLEMIC HYPERNATREMIA

70. HYPERTENSION-CAUSES

71. HYPERTENSION-MANAGEMENT

72. HYPERTENSIVE CRISIS

73. HYPERTENSIVE CRISIS-MANAGEMENT

74. HYPONATREMIA

75. HYPONATREMIA-HYPERVOLUMIC HYPONATREMIA CAUSES

76. HYPONATREMIA-HYPOVOLUMIC HYPONATREMIA CAUSES

77. HYPONATREMIA-MANAGEMENT

78. HYPONATREMIA-NORMOVOLUMIC HYPONATREMIA CAUSES

79. HYPONATREMIA-SIADH

80. INTRINSIC RENAL AKI-CAUSES

81. INTRINSIC RENAL AKI-INVESTIGATIONS

82. IgA NEPHROPATHY

83. LATE DISTAL TUBULE

84. LOOP OF HENLE

85. LUPUS NEPHRITIS

86. MAGNESIUM-HYPERMAGNESEMIA CAUSES

87. MAGNESIUM-HYPOMAGNESEMIA CAUSES

88. MEMBRANOPROLIFERATIVE GN

89. MEMBRANOUS NEPHROPATHY

90. METABOLIC ACIDOSIS-CAUSES

91. METABOLIC ACIDOSIS-DIFFERENTIALS

92. METABOLIC ALKALOSIS

93. METABOLIC ALKALOSIS-CAUSES

94. METABOLIC ALKALOSIS-MANAGEMENT

95. MICROALBUMINURIA

96. MINIMAL CHANGE DISEASE (MCD)

97. MOVEMENT OF IONS ACROSS THE RENAL TUBULES

98. MULTIPLE MYELOMA NEPHROPATHY

99. NEPHRON

100. OSMOLAL GAP

101. OSMOLALITY

102. PHOSPHATE-HYPERPHOSPHATEMIA CAUSES

103. PHOSPHATE-HYPOPHOSTHATEMIA CAUSES

104. POLYCYSTIC KIDNEY DISEASE

105. POST-INFECTIOUS GN

106. POST-RENAL AKI-CAUSES

107. POTASSIUM & ACID-BASE BALANCE

108. POTASSIUM

109. POTASSIUM, CALCIUM & MAGNESIUM

110. POTASSIUM-HYPERKALEMIA CAUSES

111. POTASSIUM-HYPERKALEMIA MANAGEMENT

112. POTASSIUM-HYPERKALEMIA MANIFESTATIONS

113. POTASSIUM-HYPOKALEMIA CAUSES

114. POTASSIUM-HYPOKALEMIA MANIFESTATIONS & MANAGEMENT

115. PRE-RENAL AKI-CAUSES

116. PRE-RENAL AKI-HEPATORENAL SYNDROME

117. PRE-RENAL AKI-INVESTIGATIONS

118. PRIMARY HYPERALDOSTERONISM

119. PRIMARY HYPERTENSION

120. PROTEINURIA

121. PROXIMAL TUBULE

122. RAPIDLY PROGRESSIVE GN (RPGN)

123. RENAL BIOPSY

124. RENAL STONES

125. RENAL STONES-CALCIUM STONES CAUSES

126. RENAL STONES-CALCIUM STONES MANAGEMENT

127. RENAL TUBULAR ACIDOSIS (RTA)-SUMMARY

128. RENAL TUBULAR ACIDOSIS

129. RENAL TUBULAR ACIDOSIS-APPROACH

130. RHABDOMYOLYSIS

131. RHABDOMYOLYSIS-CAUSES

132. RHABDOMYOLYSIS-CLINICAL & INX

133. RHABDOMYOLYSIS-MANAGEMENT

134. SECONDARY HYPERTENSION-CAUSE

135. SECONDARY HYPERTENSION-PHAEOCHROMOCYTOMA

136. SECONDARY HYPERTENSION-PREGNANCY RELATED HTN

137. SECONDARY HYPERTENSION-PRIMARY HYPERALDOSTERONISM

138. SECONDARY HYPERTENSION-RENOVASCULAR HTN

139. SECONDARY HYPERTENSION-SECONDARY HYPERALDOSTERONISM

140. SERUM CREATININE-DRUGS CAUSING RISE

141. SPOT URINE PROTEIN:CREATININE RATIO

142. TYPE 1 RENAL TUBULAR ACIDOSIS (RTA)

143. TYPE 1 RENAL TUBULAR ACIDOSIS (RTA)-CAUSES

144. TYPE 2 RENAL TUBULAR ACIDOSIS (RTA)

145. TYPE 2 RENAL TUBULAR ACIDOSIS (RTA)-CAUSES

146. TYPE 4 RENAL TUBULAR ACIDOSIS (DISTAL RTA)-CAUSES

147. TYPE 4 RENAL TUBULAR ACIDOSIS (RTA)

148. URINARY ANION GAP

149. VOLUME CONTRACTION

1. BELL'S PALSY

2. BRUDZINSKI'S SIGN

3. CAUSES OF KORSAKOFF'S PSYCHOSIS

4. KERNIG'S SIGN

5. KLUMPKE'S PLASY

6. PARINAUD'S SYNDROME

7. WERNICKE'S ENCEPHALOPATHY

8. 6 MINUTE WALKING TEST (6MWT)

9. ABDUCTION/ADDUCTION OF THE EYES

10. ACCESSORY NERVE (CN XI) SUPPLY

11. AKI-INVESTIGATIONS

12. AKINETIC MUTISM

13. ALCOHOLIC PERIPHERAL NEUROPATHY

14. ALZHEIMER DISEASE-MANAGEMENT

15. AMYOTROPHIC LATERAL SCLEROSIS

16. ANKLE FOOT ORTHOSES

17. ANTEROLATERAL WHITE COLUMN

18. ANTI-EPILEPTIC TERATOGENS

19. ANTIBODIES-ANTIPHOSPHOLIPID SYNDROME

20. APHASIA

21. APHASIA-DIFFERENT SPEECH ERRORS

22. APHASIA-RECOVERY AFTER STROKE

23. ARGYLL ROBERTSON PUPIL

24. ASCENDING TRACTS

25. BALANCE TRAINING & FALLS PREVENTION

26. BERG BALANCE SCORE

27. BPPV

28. BRACHIAL PLEXUS EXAMINATION

29. BRAIN ABSCESS

30. BRAINSTEM REFLEXES IN BRAIN DEATH TESTING

31. BULBAR VS. PSEUDOBULBAR PALSY

32. CATATONIA

33. CAUSES OF ABDUCENS PALSY

34. CAUSES OF ANOSMIA

35. CAUSES OF BILATERAL BLINDNESS

36. CAUSES OF BILATERAL FACIAL PALSY

37. CAUSES OF BINASAL HEMIANOPIA

38. CAUSES OF BITEMPORAL HEMIANOPIA

39. CAUSES OF CAROTID BRUIT

40. CAUSES OF CENTRAL SCOTOMATA

41. CAUSES OF CONCENTRIC VISUAL FIELD LOSS

42. CAUSES OF FASCICULATIONS

43. CAUSES OF HOMONYMOUS HEMIANOPIA

44. CAUSES OF HOMONYMOUS QUADRANTINOPIA

45. CAUSES OF HYPOGLOSSAL PALSY

46. CAUSES OF INTACT ACCOMODATION + IMPAIRED REACTION

47. CAUSES OF IRRITATIVE TRIGEMINAL MOTOR LESIONS

48. CAUSES OF MONOCULAR DIPLOPIA

49. CAUSES OF MYOTONIA

50. CAUSES OF OCCULOGYRIC CRISIS

51. CAUSES OF OCCULOMOTOR PALSY

52. CAUSES OF PAPILLOEDEMA

53. CAUSES OF POST-STROKE SHOULDER PAIN

54. CAUSES OF PRONATOR DRIFT

55. CAUSES OF RECURRENT LARYNGEAL NERVE PALSY

56. CAUSES OF TRIGEMINAL PALSY

57. CAUSES OF TROCHLEAR PALSY

58. CAUSES OF UNILATERAL BLINDNESS

59. CAUSES OF UNILATERAL FACIAL PALSY

60. CAUSES OF UNILATERAL GLOSSOPHARYNGEAL LESIONS

61. CAUSES OF UNILATERAL VAGAL LESIONS

62. CAUSES OF UNILATERAL VISUAL LOSS

63. CAUSES OF VERTIGO

64. CEREBELLAR SIGNS

65. CHADS2 SCORE1. Congestive cardiac failure (EF < 35%) - 1 point. 2. Hypertension (SBP > 160mmHg or treated hypertension) - 1 point. 3. Age >= 75yr - 1 point. 4. Diabetes - 1 point.5. Stroke (prior stroke or TIA) - 2 points.

66. CHARACTERISTICS OF SUPRANUCLEAR PALSY

67. CHARCOT-MARIE-TOOTH (CMT)

68. CHEDOKE-MCMASTER STROKE ASSESSMENT SCALE

69. CHORDA TYMPANI

70. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)

71. CLINICAL SIGNS

72. CLUSTER HEADACHE

73. CLUSTER HEADACHE-MANAGEMENT

74. CNS INFECTION-HIV

75. COGNITIVE DOMAINS

76. COMA

77. COMA-DECEREBRATE POSTURING

78. COMA-DECORTICATE POSTURING

79. COMA-INFRATENTORIAL ETIOLOGY

80. COMA-METABOLIC ETIOLOGY

81. COMA-OCCULOCEPHALIC TESTING

82. COMA-RESPIRATORY PATTERNS

83. COMA-SUPRATENTORIAL ETIOLOGY

84. COMMON PERONEAL NERVE-COMPRESSION

85. COMPLETE BRACHIAL PLEXUS LESION

86. CRPS TYPE 1

87. CRPS TYPE 1-DIAGNOSIS

88. CRPS TYPE 1-MANAGEMENT

89. CRPS TYPE 1-STAGES

90. CRYPTOCOCCAL MENINGITIS

91. DELIRIUM

92. DELIRIUM-EVALUATION

93. DELIRIUM-PRECIPITATING CAUSES

94. DELIRIUM-SUN-DOWNING

95. DEMENTIA TYPE-ALZHEIMER DISEASE

96. DEMENTIA TYPE-CJD

97. DEMENTIA TYPE-DIFFUSE WHITE MATTER DISEASE

98. DEMENTIA TYPE-FRONTOTEMPORAL DEMENTIA

99. DEMENTIA TYPE-HUNTINGTON CHOREA

100. DEMENTIA TYPE-MULTI-INFARCT DEMENTIA

101. DEMENTIA TYPE-PARKINSON & LEWY BODY DEMENTIA

102. DEMENTIA TYPE-PROGRESSIVE SUPRANUCLEAR PALSY

103. DEMENTIA-ALZHEIMER’S RISK FACTORS

104. DEMENTIA-DEFINITION

105. DEMENTIA-DIAGNOSIS

106. DEMENTIA-REVERSIBLE CAUSES

107. DEMENTIA-WORKUP

108. DEPRESSION VS DEMENTIA

109. DERMATOMES-C2 TO C4

110. DERMATOMES-C5 TO C8

111. DERMATOMES-L1 TO L3

112. DERMATOMES-L4 TO L5

113. DERMATOMES-S1 TO S2

114. DERMATOMES-S3 TO S5

115. DERMATOMES-T1 TO T2

116. DIABETIC NEUROPATHY

117. DIFFERENTIATE CN 3 FROM CN 4 LESION

118. DOMINANT PARIETAL LOBE SIGNS

119. DYSPHAGIA

120. DYSPHAGIA-ASPIRATION

121. DYSPHAGIA-COMPLICATIONS

122. DYSPHAGIA-FIBEROPTIC ENDOSCOPIC EVALUATION OF SWALLOWING (FFES)

123. DYSPHAGIA-PHASES OF SWALLOWING

124. DYSPHAGIA-PREVENTION OF ASPIRATION

125. DYSPHAGIA-RECOVERY AFTER STROKE

126. DYSPHAGIA-VIDEOFLUROSCOPIC SWALLOWING EVALUATION (VFS)

127. ERB DUCHENNE PALSY

128. ESSENTIAL TREMOR

129. FACIAL PALSY

130. FEEDBACK & REHABILITATION

131. FES & GAIT

132. FINGER-TO-NOSE TEST

133. FRONTAL LOBE FUNCTION

134. GENERAL INSPECTION OF THE FACE

135. GENERAL PARIETAL LOBE SIGNS

136. GENERALIZED SEIZURE-MANAGEMENT

137. GIANT CELL ARTERITIS

138. GUILLAIN-BARRE SYNDROME (GBS)

139. GUILLAIN-BARRE SYNDROME (GBS)-MANAGEMENT

140. HEADACHE

141. HEADACHE-PRIMARY HEADACHE

142. HEADACHE-SECONDARY HEADACHE

143. HSV ENCEPHALITIS

144. IDIOPATHIC INTRACRANIAL HYPERTENSION/PSEUDOTUMOR CEREBRI

145. IDIOPATHIC INTRACRANIAL HYPERTENSION/PSEUDOTUMOR CEREBRI-MANAGEMENT

146. INTERNUCLEAR OPTHALMOPLEGIA

147. KORSAKOFF SYNDROME

148. LAMBERT-EATON SYNDROME

149. LAMBERT-EATON SYNDROME-INVESTIGATION

150. LEITNER SYSTEM

151. LIGHT-TOUCH TESTING

152. LITHIUM TOXICITY

153. LOCKED-IN SYNDROME

154. MARCUS GUNN PUPILLARY SIGN

155. MEDIAN NERVE EXAMINATION

156. MENIERE DISEASE

157. MIGRAINE

158. MIGRAINE-ACUTE MANAGEMENT

159. MIGRAINE-PROPHYLACTIC MANAGEMENT

160. MIGRAINE-PROPHYLAXIS DRUGS

161. MIGRAINE-TYPES

162. MILD COGNITIVE IMPAIRMENT

163. MILD TO MODERATE PARKINSONS Tx: DOPAMINE AGONISTS

164. MILD TO MODERATE PARKINSONS Tx: MAO-B INHIBITOR

165. MOBILITY ASSESSMENT

166. MULTIPLE CRANIAL NERVE LESIONS

167. MULTIPLE SCLEROSIS-CLINICAL

168. MULTIPLE SCLEROSIS-DIAGNOSIS

169. MULTIPLE SCLEROSIS-INTRODUCTION

170. MULTIPLE SCLEROSIS-MANAGEMENT

171. MUSCLES OF THE PHARYNX AND SOFT PALATE

172. MYASTHENIA GRAVIS

173. MYASTHENIA GRAVIS-INVESTIGATIONS

174. MYASTHENIA GRAVIS-MANAGEMENT

175. MYASTHENIA GRAVIS-MYAESTHENIC CRISIS

176. MYASTHENIA GRAVIS-TYPES

177. MYOPATHY-TYPES

178. NCS-A WAVE

179. NCS-CMAP REPETITIVE STIMULATION STUDIES

180. NCS-COMPOUND MUSCLE ACTION POTENTIALS (CMAP)

181. NCS-ELECTRODIAGNOSTIC STUDIES

182. NCS-ENTRAPMENT NEUROPATHIES

183. NCS-F WAVE USES & LIMITATIONS

184. NCS-F WAVES

185. NCS-FACTORS INFLUENCING LATENCY, CV, AMPLITUDE

186. NCS-H WAVES

187. NCS-MEDIAN NEUROPATHY @ WRIST

188. NCS-MOTOR UNIT ACTION POTENTIAL (MUAP)

189. NCS-NEEDLE EMG POTENTIALS (1)

190. NCS-NEEDLE EMG POTENTIALS (2)

191. NCS-PARAMETERS

192. NCS-SNAP & CNAP

193. NCS-USES OF SNAP

194. NEURALGIC AMYOTROPHY

195. NEUROCYSTICERCOSIS

196. NEUROPATHY-MONONEUROPATHY

197. NEUROPATHY-POLYNEUROPATHY

198. NEUROPATHY-TYPES

199. NEUROPATHY-WORKUP

200. NEUROSYPHILIS

201. NON-DOMINANT PARIETAL LOBE SIGNS

202. NORMAL PRESSURE HYDROCEPHALUS

203. NYSTAGMUS

204. ONE-AND-A-HALF SYNDROME

205. PARKINSONS & PARKINSONISM-CAUSES

206. PARKINSONS & PARKINSONISM-MANAGEMENT

207. PARKINSONS & PARKINSONISM-PATHOLOGY

208. PARKINSONS & PARKINSONISM-PRESENTATION

209. PATTERNS OF VISUAL LOSS

210. PHYSIOLOGIC TREMOR

211. POST-STROKE MOBILITY INTERVENTIONS

212. POSTERIOR WHITE COLUMN

213. PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML)

214. PROGRESSIVE SUPRANUCLEAR PALSY

215. PROGRESSIVE SUPRANUCLEAR PALSY

216. QUESTION1. INX: Lesion involving dominant parietal lobe, angular gyrus.

217. QUESTION1. PRESENTATION: 33yr old lady with severe headache, fever & left sided weakness.2. BACKGROUND: Delivered healthy child 1 week prior. 3. O/E: drowsy, B/L papilloedema, right 6th nerve palsy, mild right hemiparesis. 4. INX: non-contrast CTB showed no abnormalities.

218. QUESTION1. PRESENTATION: 60yr old alcoholic man with change in mental status, muscle twitching, fibrillation.2. INX: CTB normal, EEG normal.

219. QUESTION1. PRESENTATION: 70yr old lady with hypertensive basal ganglia haemorrhage. 2. COMPLICATION: proximal lower limb DVT within 7-10 days of stroke.

220. QUESTION1. PRESENTATION: Toxoplasmosis - immunosuppressed patients (HIV, pregnancy) with undiagnosed lymphadenopathy or any granulomatous uveitis or retinitis. 2. Symptomatic acquired toxoplasmosis resembles infectious mononucleosis, and is usually self-limiting. 3. Congenital eye infection presents with posterior uveitis and may cause cataract.4. EPIDEMIOLOGY: most infections are asymptomatic - in the UK >50% are infected by 70yrs.  5. COMPLICATIONS: In the immunocompromised (e.g. AIDS) - myocarditis, encephalitis, brain lesions, stroke or seizures.

221. RADIAL NERVE EXAMINATION

222. RAMSY-HUNT SYNDROME

223. ROBOT ASSISTED MOBILITY TRAINING

224. RULES FOR TESTING CN 1

225. SEIZURE MANAGEMENT-PHENYTOIN

226. SEIZURES

227. SEIZURES-ABSENCE SEIZURES

228. SEIZURES-ACUTE MANAGEMENT

229. SEIZURES-ANTI-EPILEPTICS & OCP

230. SEIZURES-COMPLEX PARTIAL SEIZURES

231. SEIZURES-FOCAL SEIZURES

232. SEIZURES-GENERALIZED SEIZURE MANAGEMENT

233. SEIZURES-GENERALIZED TONIC-CLONIC

234. SEIZURES-MANAGEMENT OF FOCAL SEIZURES

235. SEIZURES-PREGNANCY

236. SEIZURES-RECURRENCE

237. SEIZURES-STATUS EPILEPTICUS

238. SEIZURES-STOPPING MEDICATION

239. SEROTONIN SYNDROME

240. SEVERE PARKINSONS Tx: L-DOPA

241. SHOULDER SUBLUXATION

242. SHOULDER SUBLUXATION-MANAGEMENT

243. SIMPLE GUIDE TO GLOSSOPHARYNGEAL NERVE

244. SIMPLE GUIDE TO VAGUS

245. SPASTIC EQUINOVARUS

246. SPASTICITY

247. SPASTICITY-ASSESSMENT

248. SPASTICITY-BACLOFEN

249. SPASTICITY-BENEFITS

250. SPASTICITY-BOTULINUM TOXIN SIDE EFFECTS

251. SPASTICITY-BOTULINUM TOXIN

252. SPASTICITY-CLONIDINE & TIZANIDINE

253. SPASTICITY-COMPLICATIONS

254. SPASTICITY-DANTROLENE

255. SPASTICITY-DEFINITION

256. SPASTICITY-DIAZEPAM

257. SPASTICITY-ETIOLOGY

258. SPASTICITY-INTRATHECAL BACLOFEN PUMP (ITB)

259. SPASTICITY-INTRATHECAL BACLOFEN PUMP COMPLICATIONS

260. SPASTICITY-LOCAL INTERVENTIONS

261. SPASTICITY-LOWER LIMB BOTOX

262. SPASTICITY-MANAGEMENT GOALS

263. SPASTICITY-MANAGEMENT OPTIONS

264. SPASTICITY-SPASTICITY VS. CONTRACTURE

265. SPASTICITY-UMNS MANIFESTATIONS

266. SPEECH SCREENING STEPS

267. SQUINT/STRABISMUS

268. STRENGTH TRAINING AND GAIT

269. STROKE

270. STROKE-ACA TERRITORY

271. STROKE-ANGIOGRAPHY

272. STROKE-ANTICOAGULANT THERAPY

273. STROKE-ANTIPLATELET THERAPY

274. STROKE-BASILAR ARTERY OCCLUSION SYNDROME

275. STROKE-BENEDIKT SYNDROME

276. STROKE-BLADDER DYSFUNCTION MANAGEMENT

277. STROKE-BLADDER DYSFUNCTION

278. STROKE-BODY WEIGHT SUPPORT TREADMILL TRAINING

279. STROKE-BOWEL DYSFUNCTION

280. STROKE-BRUNNSTROM STAGES OF MOTOR RECOVERY

281. STROKE-CAUSES OF MORTALITY

282. STROKE-CLASSIFICATION

283. STROKE-CONSTRAINT INDUCED MOVEMENT THERAPY (CIMT)

284. STROKE-DEPRESSION MANAGEMENT

285. STROKE-DEPRESSION

286. STROKE-ELECTRICAL STIMULATION

287. STROKE-EMBOLIC

288. STROKE-ENDARTERECTOMY

289. STROKE-HTN MANAGEMENT

290. STROKE-HYPERTENSIVE ICH

291. STROKE-ICA TERRITORY

292. STROKE-INTRA-ARTERIAL MECHANICAL THROMBECTOMY

293. STROKE-INTRA-ARTERIAL THROMBOLYTIC THERAPY

294. STROKE-INTRACEREBRAL HAEMORRHAGE

295. STROKE-LACUNAR INFARCT

296. STROKE-LATERAL MEDULLARY SYNDROME

297. STROKE-MCA (INFERIOR DIVISION) TERRITORY

298. STROKE-MCA (SUPERIOR DIVISION) TERRITORY

299. STROKE-MIRROR THERAPY & MOTOR IMAGERY

300. STROKE-MODIFIABLE RISK FACTORS

301. STROKE-MORTALITY RISK FACTORS

302. STROKE-NON-INVASIVE BRAIN STIMULATION

303. STROKE-NON-MODIFIABLE RISK FACTORS

304. STROKE-PARAMEDIAN BRAINSTEM SYNDROMES

305. STROKE-PARIETAL LESIONS

306. STROKE-PCA TERRITORY

307. STROKE-POST STROKE SHOULDER PAIN

308. STROKE-PRIMARY PREVENTION

309. STROKE-PROGNOSTIC FACTORS

310. STROKE-RESUSCITATION

311. STROKE-SEIZURES

312. STROKE-SOURCES OF EMBOLI

313. STROKE-THERAPY INTENSITY

314. STROKE-THROMBOTIC

315. STROKE-TWITCHELL (1951) STAGES OF MOTOR RECOVERY

316. STROKE-VERTEBRAL/BASILAR ARTERY OCCLUSION

317. STROKE-tPA EXCLUSION CRITERIA

318. STROKE-tPA EXLUDED PATIENTS

319. STROKE-tPA INCLUSION CRITERIA

320. STRUCTURE OF THE IRIS

321. STRUGE-WEBER SYNDROME

322. SUBACUTE COMBINED DEGENERATION OF THE SPINAL CORD

323. SWALLOWING SCREEN

324. SYRINGOMYELIA

325. TARDIVE DYSKINESIA

326. TASK-SPECIFIC TRAINING

327. TEMPORAL LOBE FUNCTION

328. TIA-COMPLICATIONS

329. TIA-RISK STRATIFICATION

330. TIA-TRANSIENT ISCHEMIC ATTACK

331. TIMED UP AND GO

332. TOXOPLASMOSIS

333. TRANSVERSE MYELITIS

334. TREADMILL TRAINING WITH/WITHOUT WEIGHT SUPPORT

335. TREATMENT FOR SPASTICITY

336. TREMORS

337. TREMORS

338. TRIGEMINAL NEURALGIA

339. TYPES OF CONJUGATE GAZE PALSY

340. TYPES OF CONJUGATE GAZE PATTERNS

341. ULNAR NERVE EXAMINATION

342. VEGETATIVE STATE

343. VERTEBROBASILAR TIA

344. VESTIBULAR NEURONITIS

345. VIRTUAL REALITY & REHABILITATION

346. WEBER AND RINNE TESTS

347. WINGING OF THE SCAPULA

1. ASIA IMPAIRMENT DESCRIPTIONS

2. ASIA IMPAIRMENT GRADING

3. ASIA IMPAIRMENT LEVELS

4. AUTONOMIC DYSREFLEXIA - CAUSES

5. AUTONOMIC DYSREFLEXIA - CLINICAL

6. AUTONOMIC DYSREFLEXIA - COMPLICATIONS

7. AUTONOMIC DYSREFLEXIA - INTRODUCTION

8. AUTONOMIC DYSREFLEXIA - MANAGEMENT

9. AUTONOMIC DYSREFLEXIA - MECHANISM

10. AUTONOMIC DYSREFLEXIA - PATHOPHYSIOLOGY

11. BOTULINUM TOXIN SIDE EFFECTS

12. BOTULINUM TOXIN

13. BOWEL WALL LAYERS

14. BROWN-SEQUARD SYNDROME

15. CAUSES OF COMA IN SAH

16. CENTRAL CORD SYNDROME

17. CLINICAL FINDINGS IN SAH

18. COLON

19. CORRELATING CT FINDINGS WITH ANEURYSM LOCATION

20. CRUCIATE PARALYSIS

21. CT SCAN IN SAH

22. EASY ASIA GRADING

23. ENTERIC ELECTRICAL ACTIVITY

24. ENTERIC PLEXUS

25. EVALUATING FOR SAH

26. GASTRIC MUCOSAL GLANDS

27. GIT CHANGES AFTER SCI

28. GIT NEUROTRANSMITTERS

29. GIT PARASYMPATHETIC SUPPLY

30. GIT REFLEXES

31. GIT SYMPATHETIC SUPPLY

32. INTRODUCTION

33. LP FINDINGS

34. LUMBAR PUNCTURE

35. OCCULAR HAEMORRHAGE IN SAH

36. OPTIONAL ADDITIONAL MUSCLE TESTING

37. OUTCOME OF ANEURYSMAL SAH

38. RISK FACTORS

39. SAH STATISTICS

40. UMN/LMN BOWEL

41. WFNS SCALE

42. XANTHOCHROMIA TIMING

1. WEGNER'S GRANULOMATOSIS

2. WEGNER'S GRANULOMATOSIS-DIAGNOSIS

3. WEGNER'S GRANULOMATOSIS-INVESTIGATION

4. WEGNER'S GRANULOMATOSIS-MANAGEMENT

5. ABNORMAL BREATHING PATTERNS

6. ASTHMA

7. ASTHMA-CAUSES

8. ASTHMA-DRUGS

9. ASTHMA-MANAGEMENT SUMMARY

10. AUSCULTATION FINDINGS

11. COPD

12. COPD-HOME OXYGEN

13. GENERAL CAUSES OF DYSPNOEA

14. INSPECT THE CHEST (FRONT & BACK)

15. PULMONARY EMBOLISM

16. PULMONARY EMBOLISM-ABG

17. PULMONARY EMBOLISM-ALGORITHM

18. PULMONARY EMBOLISM-ANTICOAGULANT CONTRAINDICATIONS

19. PULMONARY EMBOLISM-CLINICAL

20. PULMONARY EMBOLISM-CTPA & VQ SCAN

21. PULMONARY EMBOLISM-CXR

22. PULMONARY EMBOLISM-DURATION OF TREATMENT

23. PULMONARY EMBOLISM-DVT

24. PULMONARY EMBOLISM-ECG

25. PULMONARY EMBOLISM-MANAGEMENT

26. PULMONARY EMBOLISM-PATHOLOGY

27. PULMONARY EMBOLISM-THROMBOLYTICS

28. PULMONARY EMBOLISM-WELLS CRITERIA

29. PULMONARY SARCOIDOSIS

30. PULMONARY SARCOIDOSIS-DIFFERENTIALS

31. PULMONARY SARCOIDOSIS-INVESTIGATION

32. PULMONARY SARCOIDOSIS-MANAGEMENT

33. PULMONARY SARCOIDOSIS-SYSTEMIC CORTICOSTEROIDS

34. SUDDEN ONSET DYSPNOEA DIFFERENTIALS

35. TYPES OF CRACKLES

36. VOCAL RESONANCE FINDINGS

1. ADULT-ONSET STILL'S DISEASE

2. MORTON'S NEUROMA

3. REYNAUD'S PHENOMENON-CAUSES

4. SJOGREN'S SYNDROME

5. ACHILLES TENDON RUPTURE

6. ACL INJURY

7. ADHESIVE CAPSULITIS

8. ANKLE SPRAIN

9. ANKLE SPRAIN-INX & MANAGEMENT

10. ANKYLOSING SPONDYLITIS

11. ANKYLOSING SPONDYLITIS-INVESTIGATION

12. ANKYLOSING SPONDYLITIS-MANAGEMENT

13. ANTIBODIES-ANCA

14. ANTIBODIES-ANTINUCLEAR ANTIBODIES

15. ANTIBODIES-SPECIFIC ANTINUCLEAR ANTIBODIES

16. ANTIPHOSPHOLIPID SYNDROME

17. ANTIPHOSPHOLIPID SYNDROME-CLINICAL

18. ANTIPHOSPHOLIPID SYNDROME-MANAGEMENT

19. BOUTONNIERE (BUTTONHOLE) DEFORMITY

20. BURSITIS

21. CAUSES OF APPARENT LL LENGTH DISCREPANCY

22. CAUSES OF BACK PAIN

23. CAUSES OF JOINT SWELLING

24. CAUSES OF LIMB PAIN

25. CAUSES OF MONOARTHRITIS

26. CAUSES OF PAINLESS RED EYES

27. CAUSES OF POLYARTHRITIS

28. CAUSES OF TRUE LL LENGTH DISCREPANCY

29. CHARCOT JOINTS

30. CHURG-STRAUSS SYNDROME

31. COMPARTMENT SYNDROME

32. COMPLEX REGIONAL PAIN SYNDROME

33. CPPD DEPOSITION DISEASE

34. CPPD DEPOSITION DISEASE-INVESTIGATION

35. CPPD DEPOSITION DISEASE-MANAGEMENT

36. CRYSTALS

37. DERMATOMYOSITIS & POLYMYOSITIS MANAGEMENT

38. DERMATOMYOSITIS

39. DIABETIC CHEIROARTHRITIS

40. DRUG INDUCED LUPUS

41. DRUG-INDUCED MYOPATHY

42. FIBROMYALGIA

43. FIFTH METATARSAL STRESS FRACTURE

44. GONOCOCCAL ARTHRITIS

45. GOUT

46. GOUT-ACUTE MANAGEMENT

47. GOUT-CHRONIC MANAGEMENT

48. GOUT-CLINICAL

49. GOUT-DECREASED URIC ACID EXCRETION

50. GOUT-INCREASED URIC ACID PRODUCTION

51. GOUT-INVESTIGATIONS

52. GOUT-RADIOGRAPHY

53. GOUT-RISK FACTORS

54. HAMSTRING STRAIN

55. HAND-JOINTS INVOLVED

56. HEMOSTASIS-INVESTIGATIONS

57. HEMOSTASIS-THROMBUS DISSOLUTION

58. HIP DISLOCATION

59. HISTORY - MISCELLANEOUS JOINT ASSOCIATED CONDITIONS

60. INCLUSION BODY MYOSITIS

61. INFLAMMATORY BACK PAIN

62. LABRAL INJURIES

63. MCL INJURY

64. MHC-HLA B27

65. MHC-HUMAN LEUKOCYTE ANTIGENS (HLA)

66. MIXED CONNECTIVE TISSUE DISEASE

67. MSK DISORDERS

68. MYOSITIS OSSIFICANS

69. NAIL CHANGES

70. NAVICULAR FRACTURE

71. NON-GONOCOCCAL ARTHRITIS

72. OA-HIPS, KNEES, ANKLES

73. OSTEOARTHRITIS

74. OSTEOARTHRITIS-HANDS

75. OSTEOARTHRITIS-HIPS

76. OSTEOARTHRITIS-KNEES

77. OSTEOCHONDRITIS DESSICANS

78. PATTERNS OF RHEUMATOLOGICAL PRESENTATION

79. PIPJ AND DIPJ NODULES

80. PLANTAR FASCITIS

81. POLYARTERITIS NODOSA

82. POLYARTERITIS NODOSA-CLINICAL & MANAGEMENT

83. POLYMYALGIA RHEUMATICA-HISTORY

84. POLYMYALGIA RHEUMATICA-INVESTIGATIONS

85. POLYMYALGIA RHEUMATICA-MANAGEMENT

86. POLYMYOSITIS

87. PREPATELLAR BURSITIS

88. PRIMARY HEMOSTASIS DISORDERS-THROMBOCYTOPENIA

89. PSORIATIC ARTHRITIS

90. PSORIATIC ARTHRITIS-MANAGEMENT

91. RADIOLOGICAL CHANGES IN ANKYLOSING SPONDYLITIS

92. RADIOLOGICAL CHANGES IN GOUT

93. RADIOLOGICAL CHANGES IN RA

94. RAYNAUD PHENOMENON

95. RAYNAUD PHENOMENON-INVESTIGATION & MANAGEMENT

96. REACTIVE ARTHRITIS

97. REACTIVE ARTHRITIS-MANAGEMENT

98. RHEUMATOID ARTHRITIS-BIOLOGIC AGENTS

99. RHEUMATOID ARTHRITIS-CLINICAL

100. RHEUMATOID ARTHRITIS-DIAGNOSIS

101. RHEUMATOID ARTHRITIS-DRUGS IN PREGNANCY

102. RHEUMATOID ARTHRITIS-EXTRA-ARTICULAR MANIFESTATIONS

103. RHEUMATOID ARTHRITIS-INTRODUCTION

104. RHEUMATOID ARTHRITIS-INVESTIGATIONS

105. RHEUMATOID ARTHRITIS-JOINTS & RADIOLOGY

106. RHEUMATOID ARTHRITIS-LOWER LIMBS

107. RHEUMATOID ARTHRITIS-MANAGEMENT

108. RHEUMATOID ARTHRITIS-OTHER AGENTS

109. RHEUMATOID ARTHRITIS-POOR PROGNOSIS

110. RHEUMATOID ARTHRITIS-SYSTEMIC

111. RHEUMATOID ARTHRITIS-UPPER LIMBS

112. RHEUMATOID FACTOR AND ANTI-CCP

113. RHEUMATOID NODULES

114. SEPTIC ARTHRITIS

115. SERONEGATIVE SPONDYLOARTHRITIS

116. SJOGREN SYNDROME

117. STRESS FRACTURES

118. STRESS FRACTURES-AVN

119. STRESS FRACTURES-FEMORAL NECK

120. STRESS FRACTURES-MANAGEMENT

121. STRESS FRACTURES-TIBIA

122. SWAN NECK DEFORMITY

123. SYNOVIAL FLUID

124. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-BLOOD

125. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-CNS

126. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-CRITERIA

127. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-HEART & LUNGS

128. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-INVESTIGATIONS

129. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-JOINTS

130. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-MANAGEMENT

131. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-PREGNANCY

132. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-RASH

133. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)-RENAL

134. SYSTEMIC SCLEROSIS

135. SYSTEMIC SCLEROSIS-DIFFUSE & LIMITED

136. SYSTEMIC SCLEROSIS-GI

137. SYSTEMIC SCLEROSIS-KIDNEYS

138. SYSTEMIC SCLEROSIS-LUNGS

139. SYSTEMIC SCLEROSIS-MANAGEMENT

140. SYSTEMIC SCLEROSIS-SKIN

141. TAKAYASU ARTERITIS

142. THORACIC OUTLET SYNDROME

143. TP OVERLOAD/MEDIAL TIBIAL STRESS SYNDROME

144. TROCHANTERIC BURSITIS

145. TUBERCULOUS ARTHRITIS

146. VASCULITIS

147. WHIPPLE DISEASE

148. Z DEFORMITY